Analyst Ratings for Audentes Therapeutics (BOLD) [Neutrals]

BOLD Rating Summary

  |   Expand Research on BOLD
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0.6 / 10   Percentile Rank: 6%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/9/2019 Evercore ISI Joshua Schimmer Downgrade In Line
(Outperform)
N/A
(N/A)
59.25
(59.97)
1.22% Details
12/5/2019 JPMorgan Anupam Rama Downgrade Neutral
(Overweight)
60.00
(44.00)
59.30
(59.97)
1.13% Details
Like BOLD Ratings? Also take a look at

BOLD Ratings News